Regeneron · 2 hours ago
Clinical Imaging Scientific Director (Oncology)
Tarrytown, NY
Full-time
Onsite
Director/Executive
$202K/yr - $337K/yr
10+ years expRegeneron is a leading biotechnology company focused on innovative medicines. The Clinical Imaging Scientific Director for Oncology will develop and execute imaging strategies for oncology clinical trials, collaborate with various teams, and lead the interaction with regulatory agencies regarding imaging endpoints.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Create fit-for-purpose imaging biomarker strategies and work closely with research, clinical imaging and the oncology therapeutic area for the development of imaging endpoints to inform and advance the Regeneron clinical pipeline
Prepare and present clinical imaging strategies to senior management
Manage a complex network of stakeholders across Regeneron
Lead, design and implement multi-modality imaging measures as endpoints for oncology therapeutic clinical studies
Collaborate closely with Regeneron clinical teams as imaging subject matter expert to ensure optimal design and execution of imaging strategy including development of protocols, imaging endpoints, imaging manuals, imaging charters, statistical analysis plans and clinical study reports
Work closely with Clinical Imaging Operations and imaging contract research organizations to ensure the flawless conduct and data integrity of studies’ imaging components and endpoints
Serve as Study Scientific Director for clinical trials focused on qualification and utilization of novel imaging biomarkers
Lead the interaction with regulatory agencies for communications regarding imaging endpoints and procedures
Lead the interaction with regulatory agencies and site ethic committees for approval of clinical imaging biomarker development studies
Qualification
Required
PhD with a minimum of 10+ years of clinical imaging experience (minimum of 7 years within oncology drug development)
Experience as study scientific director of PET imaging biomarker clinical trials in Oncology
Experience applying PET imaging as a quantitative endpoint in clinical and preclinical studies in Oncology
People management experience
Direct experience with preclinical oncology imaging models using PET and immuno-PET imaging biomarkers
Strong background in oncology, biology, molecular imaging, radiopharmaceuticals and familiar with precision medicine approaches
Imaging CRO oversight and implementation of quality control procedures
Experience implementing central efficacy assessments using tumor response criteria such as RECIST 1.1, iRECIST, PCWG3, Lugano and IMWG in oncology clinical trials
Successful engagement experience with regulatory agencies
Ability to champion imaging innovations and lead projects effectively
Benefits
Health and wellness programs
Fitness centers
Equity awards
Annual bonuses
Paid time off for eligible employees at all levels
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
10001+ employees
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Aris Baras
Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center
Bari Kowal
Senior Vice President, Head Development Operations & Portfolio Management
Recent News
Pharmaceutical Technology
2025-12-29
Company data provided by crunchbase